PMNT insider files Form 4 for 148,958 stock options
Rhea-AI Filing Summary
Andre R. Keijsers, a director of Perfect Moment Ltd. (PMNT), was granted employee stock options totaling 148,958 shares across three option awards. The largest grant—65,758 options—was granted on 10/01/2025 with an exercise price of $0.46, exercisable starting 12/31/2025 and expiring 10/01/2035; that grant vests in four installments (two of 16,440 and two of 16,439) across 12/31/2025 through 09/30/2026. A separate 40,000-option award at $0.48 shows 09/18/2025 with an expiration of 09/17/2035. An earlier 43,200-option award at $4.10 from 10/25/2024 expires 03/04/2034. The Form 4 is filed individually by Keijsers and reflects these non-derivative and derivative option holdings reported as direct ownership.
Positive
- Director alignment: Grants tie director compensation to long‑term share performance with vesting through 09/30/2026
- Retention-focused vesting: Largest award vests in four installments, supporting continuity over the next year
Negative
- Potential dilution: Up to 148,958 shares could be issued if all options are exercised
- Near-term vesting: 16,440 options become exercisable on 12/31/2025, which could increase share count within 12 months
Insights
Director received multi‑year option awards totaling 148,958 shares with staged vesting.
The option grants align the director's pay with long‑term shareholder outcomes by tying value to future share price movement over multi‑year vesting and long expirations through 2035. The largest tranche vests in four installments between 12/31/2025 and 09/30/2026, creating retention incentives across the next year.
The main dependences are future stock performance and potential dilution; the grants add 148,958 underlying shares that could convert to common stock if exercised. Monitor outstanding option exercise behavior and reported shares outstanding over the next 12–24 months for dilution impact.
Strike prices span $0.46 to $4.10, implying different grant vintages and potential upside if share price rises.
Lower strike prices on the recent grants ($0.46 and $0.48) reflect current award terms and set a break‑even threshold for value capture. The older $4.10 award remains outstanding and may be underwater or in‑the‑money depending on current market price.
Watch reported market price relative to these strikes and any near‑term exercises; exercise activity over the next 12 months will determine cash proceeds to the company and actual share dilution timing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Options (right to buy) | 65,758 | $0.00 | -- |
| holding | Employee Stock Options (right to buy) | -- | -- | -- |
| holding | Employee Stock Options (right to buy) | -- | -- | -- |
Footnotes (1)
- Employee stock options (right to buy) ("Options") granted pursuant to Issuer's 2021 Equity Incentive Plan, as amended. Options vest and are exercisable as follows: 16,440 Options on December 31, 2025 and March 31, 2026, and 16,439 Options on June 30, 2026 and September 30, 2026. Not applicable.
